logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hengrui Pharmaceuticals (01276.HK) spent 61.3569 million yuan on September 26th to repurchase 883400 shares of A shares.

date
26/09/2025
Zhtng Cijng APP News, Hng Ru Yyo (01276.HK) announced that on September 26, 2025, the company spent 61.3569 million RMB to repurchase 883,400 A-shares, with a repurchase price of 69.25-69.81 RMB per share.
Latest
3 m ago
Central Bank: The cost of social financing is at a historically low level, and the overall operation of the financial market is stable.
3 m ago
Shenzhou Digital (000034.SZ) subsidiary intends to sign a 39.95 million yuan database software contract with Southern Airlines.
5 m ago
Polish central bank: The objective of monetary policy is to maintain the consumer price index at a level of 1.5% - 3.5%.
5 m ago
Hengjia Financial Leasing (00379.HK): Non-executive director Ye Minyi passes away
6 m ago
The central bank: Increase the vitality of existing commercial housing and existing land inventory to consolidate the stable trend of the real estate market.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.